Cara Therapeutics Inc

NASDAQ:CARA   3:59:50 PM EDT
12.91
+0.30 (+2.38%)
Earnings Announcements

Cara Therapeutics Reports Q3 2021 Financial Results

Published: 11/08/2021 21:33 GMT
Cara Therapeutics Inc (CARA) - Cara Therapeutics Reports Third Quarter 2021 Financial Results.
Q3 Loss per Share $0.02.
Revenue is expected to be $1.46 Million
Adjusted EPS is expected to be -$0.52

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.64

More details on our Analysts Page.